Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8278294 Substituted isoquinoline and isoquinolinone derivatives as inhibitors of Rho-kinase

Patent 8278294 was granted and assigned to Sanofi on October, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Sanofi

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

82782940

Patent Inventor Names

Matthias Lohn0

Armin Hofmeister0

Joachim Brendel0

Oliver Plettenburg0

Date of Patent

October 2, 2012

Patent Application Number

124874030

Date Filed

June 18, 2009

Patent Citations Received

‌

US Patent 11891376 Aryl cyclopropyl-amino-isoquinolinyl amide compounds

‌

US Patent 12018012 Aryl cyclopropyl-amino-isoquinolinyl amide compounds

‌

US Patent 11707460 Ophthalmic compositions

Patent Primary Examiner

‌

Brandon Fetterolf

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8278294 Substituted isoquinoline and isoquinolinone derivatives as inhibitors of Rho-kinase

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API